Flexion Therapeutics
Zilretta, an extended-release intra-articular steroid injection for knee osteoarthritis pain
- Sector
- Medtech
- Headquarters
- WOBURN, MA
- Founded
- 2007
- Latest Form D
- $20M, Dec 2012
- Total capital
- $40M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $40M
- 2 Form D · last Dec 2012
- 166 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 28 pending · first 2017
- Rank in peer group#4 of 29
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$20M
- Private capital raisedForm D · SEC · 1st filing$20M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 29 peers
Line = medianMedtech · Molecule
- Granted patents#4 · top 14%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- NEIL BODICKResearcherExecutive OfficerLinked by 4 patents
- Alan MilinazzoDirectorNamed in SEC Form D filings
- Andrew SchwabDirectorNamed in SEC Form D filings
- Arthur FratamicoExecutive OfficerNamed in SEC Form D filings
- BRADLEY BOLZONDirectorNamed in SEC Form D filings
- Elaine JonesDirectorNamed in SEC Form D filings
Show all 11 people
- Heath LukatchDirectorNamed in SEC Form D filings
- MICHAEL CLAYMANExecutive Officer, DirectorNamed in SEC Form D filings
- Patrick MahaffyDirectorNamed in SEC Form D filings
- RAFAELE TORDJMANDirectorNamed in SEC Form D filings
- SAMUEL COLELLADirectorNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 32- GrantedCorticosteroids For The Treatment Of Joint PainUSPTOUS 10,624,905
- PendingFluticasone Extended-release Formulations And Methods Of Use ThereofUSPTOApplication 16493437
- GrantedCorticosteroids For The Treatment Of Joint PainUSPTOUS 9,949,987
Show all 32 patent records
- Corticosteroids For The Treatment Of Joint PainApr 21, 2020 · US 10,624,905Granted
- Fluticasone Extended-release Formulations And Methods Of Use ThereofJan 9, 2020 · Application 16493437Pending
- Corticosteroids For The Treatment Of Joint PainApr 24, 2018 · US 9,949,987Granted
- Corticosteroid Formulations And Methods For The Treatment Of Joint Pain In Patients With DiabetesSep 14, 2017 · Application 15458383Pending
- Corticosteroids For The Treatment Of Joint PainMay 18, 2017 · Application 15420829Pending
- Corticosteroid Formulations For Maintaining Corticosteroid Synovial Fluid ConcentrationsApr 13, 2017 · Application 15292670Pending
- Corticosteroids For The Treatment Of Joint PainJan 31, 2017 · US 9,555,047Granted
- Corticosteroids for the Treatment of Joint PainJan 31, 2017 · US 9,555,048Granted
- Corticosteroids for the Treatment of Joint PainAug 28, 2014 · Application 14107188Pending
- Fluticasone Formulations And Methods Of Use ThereofApplication PCTUS2017066816Pending
- Fluticasone Extended-release Formulations And Methods Of Use ThereofApplication 62473029Pending
- Corticosteroid Formulations And Methods For The Treatment Of Joint Pain In Patients With DiabetesApplication PCTUS2017022277Pending
- Fluticasone Formulations And Methods Of Use ThereofApplication 62434690Pending
- Corticosteroid Formulations For Maintaining Corticosteroid Synovial Fluid ConcentrationsApplication PCTUS2016056803Pending
- Corticosteroid Formulations And Methods For The Treatment Of Joint Pain In Patients With DiabetesApplication 62323360Pending
- Corticosteroid Formulations And Methods For The Treatment Of Joint Pain In Patients With Type 2 DiabetesApplication 62307879Pending
- Corticosteroid Formulations For Maintaining Corticosteroid Synovial Fluid ConcentrationsApplication 62240811Pending
- Corticosteroid Formulations For The Treatment Of Joint Pain And Methods Of Use ThereofApplication PCTUS2014031167Pending
- Corticosteroid Formulations For The Treatment Of Joint Pain And Methods Of Use ThereofApplication 61831030Pending
- Corticosteroid Formulations For The Treatment Of Joint Pain And Methods Of Use ThereofApplication 61822654Pending
- Corticosteroid Formulations For The Treatment Of Joint Pain And Methods Of Use ThereofApplication 61803129Pending
- Corticosteroids For The Treatment Of Joint PainApplication PCTUS2012024240Pending
- Sustained Release Thermosetting Gels Comprising Sodium Channel Blockers And The Methods Of Making The SameApplication 63159234Pending
- Corticosteroids For The Treatment Of Joint PainApplication PCTUS2011046601Pending
- Sustained Release Thermosetting Gels Comprising Anesthetic Drugs And The Methods Of Making The SameApplication 63159229Pending
- Sustained Release Thermosetting Gels Comprising Sodium Chanel Blockers And The Methods Of Making The SameApplication 63026369Pending
- Effective Dosages Of An Adenoviral-based Biological Delivery And Expression System For Use In The Treatment Of Osteoarthritis In Humans, And Compositions Comprising The SameApplication 62966632Pending
- Sustained Release Thermosetting Gels Comprising Sodium Chanel Blockers And The Methods Of Making The SameApplication 62958212Pending
- Title Of The Invention: Sustained Release Thermosetting Gels Comprising Sodium Chanel Blockers And The Methods Of Making The SameApplication 62932076Pending
- Effective Dosages Of An Adenoviral-based Biological Delivery And Expression System For Use In The Treatment Of Osteoarthritis In Humans, And Compositions Comprising The SameApplication 62902041Pending
- Sustained Release Thermosetting Gels Comprising Sodium Chanel Blockers And The Methods Of Making SameApplication 62897555Pending
- Fluticasone Extended-release Formulations And Methods Of Use ThereofApplication PCTUS2018022848Pending
Related companies, and why
- Contra Healthcare Solutions, LLCSimilar federal contract value in Medtech · null in contracts
- Soteria Battery Innovation Group Inc.Similar federal contract value in Medtech · null in contracts
- ARTVENTIVE MEDICAL GROUP, INC.Similar federal contract value in Medtech · null in contracts
- Light in the Tunnel LLCSimilar federal contract value in Medtech · null in contracts
- Lite Run, Inc.Similar federal contract value in Medtech · null in contracts
- XCR Diagnostics IncSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .